# Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery

> **NCT00847964** · PHASE2 · COMPLETED · sponsor: **LoneStar Heart, Inc.** · enrollment: 11 (actual)

## Conditions studied

- Dilated Cardiomyopathy

## Interventions

- **DEVICE:** Algisyl-LVR

## Key facts

- **NCT ID:** NCT00847964
- **Lead sponsor:** LoneStar Heart, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2011-11
- **Final completion:** 2012-11
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2012-11-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00847964

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00847964, "Safety and Feasibility of Algisyl-LVR™ as a Method of Left Ventricular Restoration in Patients With DCM Undergoing Open-heart Surgery". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00847964. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*